These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 15084608

  • 1. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
    Liao G, Zhang M, Harhaj EW, Sun SC.
    J Biol Chem; 2004 Jun 18; 279(25):26243-50. PubMed ID: 15084608
    [Abstract] [Full Text] [Related]

  • 2. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
    Morrison MD, Reiley W, Zhang M, Sun SC.
    J Biol Chem; 2005 Mar 18; 280(11):10018-24. PubMed ID: 15644327
    [Abstract] [Full Text] [Related]

  • 3. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A, Hori T, Fukunaga K, Morita R, Kawamata S, Uchiyama T.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):856-63. PubMed ID: 10860842
    [Abstract] [Full Text] [Related]

  • 4. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B, Zarnegar B, Ytterberg AJ, Shiba T, Dempsey PW, Ware CF, Loo JA, Cheng G.
    Sci Signal; 2010 May 25; 3(123):ra41. PubMed ID: 20501937
    [Abstract] [Full Text] [Related]

  • 5. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
    He JQ, Saha SK, Kang JR, Zarnegar B, Cheng G.
    J Biol Chem; 2007 Feb 09; 282(6):3688-94. PubMed ID: 17158868
    [Abstract] [Full Text] [Related]

  • 6. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
    Van Huffel S, Delaei F, Heyninck K, De Valck D, Beyaert R.
    J Biol Chem; 2001 Aug 10; 276(32):30216-23. PubMed ID: 11390377
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM, Lee DW, Jung JU, Sitcheran R.
    Mol Cancer; 2015 Jan 27; 14(1):9. PubMed ID: 25622756
    [Abstract] [Full Text] [Related]

  • 8. Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury.
    Jiang B, Shen H, Chen Z, Yin L, Zan L, Rui L.
    J Biol Chem; 2015 May 01; 290(18):11704-14. PubMed ID: 25792747
    [Abstract] [Full Text] [Related]

  • 9. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.
    Hu WH, Pendergast JS, Mo XM, Brambilla R, Bracchi-Ricard V, Li F, Walters WM, Blits B, He L, Schaal SM, Bethea JR.
    J Biol Chem; 2005 Aug 12; 280(32):29233-41. PubMed ID: 15951441
    [Abstract] [Full Text] [Related]

  • 10. The noncanonical NF-κB pathway.
    Sun SC.
    Immunol Rev; 2012 Mar 12; 246(1):125-40. PubMed ID: 22435551
    [Abstract] [Full Text] [Related]

  • 11. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
    Funakoshi M, Tago K, Sonoda Y, Tominaga S, Kasahara T.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):248-54. PubMed ID: 11322796
    [Abstract] [Full Text] [Related]

  • 12. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    Yang CH, Murti A, Pfeffer LM.
    J Biol Chem; 2005 Sep 09; 280(36):31530-6. PubMed ID: 16009713
    [Abstract] [Full Text] [Related]

  • 13. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A, Kaisho T, Rennert PD, Nakano H, Kurosawa K, Uchida D, Takeda K, Akira S, Matsumoto M.
    J Exp Med; 2001 Mar 05; 193(5):631-6. PubMed ID: 11238593
    [Abstract] [Full Text] [Related]

  • 14. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
    Zarnegar B, Yamazaki S, He JQ, Cheng G.
    Proc Natl Acad Sci U S A; 2008 Mar 04; 105(9):3503-8. PubMed ID: 18292232
    [Abstract] [Full Text] [Related]

  • 15. Molecular determinants of NF-kappaB-inducing kinase action.
    Lin X, Mu Y, Cunningham ET, Marcu KB, Geleziunas R, Greene WC.
    Mol Cell Biol; 1998 Oct 04; 18(10):5899-907. PubMed ID: 9742107
    [Abstract] [Full Text] [Related]

  • 16. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG, Ni J, Moore PA, Aggarwal BB.
    J Biol Chem; 1999 Mar 19; 274(12):7724-31. PubMed ID: 10075662
    [Abstract] [Full Text] [Related]

  • 17. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K.
    Nature; 1999 Mar 18; 398(6724):252-6. PubMed ID: 10094049
    [Abstract] [Full Text] [Related]

  • 18. CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation.
    Hong X, Xu L, Li X, Zhai Z, Shu H.
    FEBS Lett; 2001 Jun 15; 499(1-2):133-6. PubMed ID: 11418127
    [Abstract] [Full Text] [Related]

  • 19. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
    Gray CM, Remouchamps C, McCorkell KA, Solt LA, Dejardin E, Orange JS, May MJ.
    Sci Signal; 2014 Feb 04; 7(311):ra13. PubMed ID: 24497610
    [Abstract] [Full Text] [Related]

  • 20. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
    Razani B, Reichardt AD, Cheng G.
    Immunol Rev; 2011 Nov 04; 244(1):44-54. PubMed ID: 22017430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.